FDA NDC Directory · JSON-LD · Markdown

CABERGOLINE

NDC 70069-824 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerSomerset Therapeutics, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA218109
Dosage form / routeTABLET · ORAL
Active ingredientsCABERGOLINE (.5 mg/1)
Marketing started20241018
Package count1

External sources

Source: openFDA. Public-domain (CC0).